XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - CAD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 567 $ 310
Restricted cash (note 32) 21 22
Inventory (note 14) 790 769
Derivative instruments (notes 15 and 16) 174 296
Regulatory assets (note 6) 339 602
Receivables and other current assets (note 18) 1,817 2,897
Total current assets 3,708 4,896
Property, plant and equipment ("PP&E"), net of accumulated depreciation and amortization of $9,994 and $9,574, respectively (note 20) 24,376 22,996
Other assets    
Deferred income taxes (note 10) 208 237
Derivative instruments (notes 15 and 16) 66 100
Regulatory assets (note 6) 2,766 3,018
Net investment in direct finance and sales type leases (note 19) 621 604
Investments subject to significant influence (note 7) 1,402 1,418
Goodwill (note 22) 5,871 6,012
Other long-term assets (note 32) 462 461
Total other assets 11,396 11,850
Total assets 39,480 39,742
Current liabilities    
Short-term debt (note 23) 1,433 2,726
Current portion of long-term debt (note 25) 676 574
Accounts payable 1,454 2,025
Derivative instruments (notes 15 and 16) 386 888
Regulatory liabilities (note 6) 168 495
Other current liabilities (note 24) 427 579
Total current liabilities 4,544 7,287
Long-term liabilities    
Long-term debt (note 25) 17,689 15,744
Deferred income taxes (note 10) 2,352 2,196
Derivative instruments (notes 15 and 16) 118 190
Regulatory liabilities (note 6) 1,604 1,778
Pension and post-retirement liabilities (note 21) 265 281
Other long-term liabilities (notes 7 and 26) 820 825
Total long-term liabilities 22,848 21,014
Equity    
Common stock (note 11) 8,462 7,762
Cumulative preferred stock (note 28) 1,422 1,422
Contributed surplus 82 81
Accumulated other comprehensive income ("AOCI") (note 13) 305 578
Retained earnings 1,803 1,584
Total Emera Incorporated equity 12,074 11,427
Non-controlling interest in subsidiaries (note 29) 14 14
Total equity 12,088 11,441
Total liabilities and equity $ 39,480 $ 39,742